Rabeprazole 20mg gastro resistant tablets smpc- taj pharmaceuticalsTaj Pharma
Rabeprazole Taj Pharma : Uses, Side Effects, Interactions, Pictures, Warnings, Rabeprazole Dosage & Rx Info | Rabeprazole Uses, Side Effects -: Indications, Side Effects, Warnings, Rabeprazole - Drug Information - Taj Pharma, Rabeprazole dose Taj pharmaceuticals Rabeprazole interactions, Taj Pharmaceutical Rabeprazole contraindications, Rabeprazole price, Rabeprazole Taj Pharma Rabeprazole 20mg Gastro-resistant Tablets SMPC- Taj Pharma . Stay connected to all updated on Rabeprazole Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Captopril Tablets SmPC Taj PharmaceuticalsTajPharmaQC
Captopril Tablets USP 25mg, 50mg, 100mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Captopril Dosage & Rx Info | Captopril Uses, Side Effects Captopril: Indications, Side Effects, Warnings, Captopril -Drug Information –Taj Pharma, Captopril dose Taj pharmaceuticals Captopril interactions, Taj Pharmaceutical Captopril contraindications, Captopril price, Captopril Taj Pharma Captopril SmPC- Taj Pharma Stay connected to all updated on Captopril Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
Chlorambucil Tablets 2mg USP Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Chlorambucil Dosage & Rx Info | Chlorambucil Uses, Side Effects Chlorambucil: Indications, Side Effects, Warnings, Chlorambucil -Drug Information –Taj Pharma, Chlorambucil dose Taj pharmaceuticals Chlorambucil interactions, Taj Pharmaceutical Chlorambucil contraindications, Chlorambucil price, Chlorambucil Taj Pharma Chlorambucil SmPC-Taj Pharma Stay connected to all updated on Chlorambucil Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
Cefpodoxime 100mg film coated tablets smpc- taj pharmaceuticalsTaj Pharma
Cefpodoxime Dosage & Rx Info | Cefpodoxime Uses, Side Effects -: Indications, Side Effects, Warnings, Cefpodoxime - Drug Information - Taj Pharma, Cefpodoxime dose Taj pharmaceuticals Cefpodoxime interactions, Taj Pharmaceutical Cefpodoxime contraindications, Cefpodoxime price, Cefpodoxime Taj Pharma Cefpodoxime 100mg Film-Coated Tablets SMPC- Taj Pharma . Stay connected to all updated on Cefpodoxime Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Omeprazole 20mg gastro resistant capsules smpc taj pharmaceuticalsTaj Pharma
Omeprazole - Drug Information - Taj Pharma, Omeprazole dose Taj pharmaceuticals Omeprazole interactions, Taj Pharmaceutical Omeprazole contraindications, Omeprazole price, Omeprazole Taj Pharma Omeprazole 20mg Gastro-resistant Capsules SMPC- Taj Pharma . Stay connected to all updated on Omeprazole Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Cabazitaxel 60 mg concentrate and solvent for solution for infusion smpc taj...Taj Pharma
CABAZITAXEL - Drug Information - Taj Pharma, CABAZITAXEL dose Taj pharmaceuticals CABAZITAXEL interactions, Taj Pharmaceutical CABAZITAXEL contraindications, CABAZITAXEL price, CABAZITAXEL Taj Pharma Cancer, oncologyCABAZITAXEL 60 mg concentrate and solvent for solution for infusion. SMPC- Taj Pharma . Stay connected to all updated on CABAZITAXEL Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Carboplatin Injection BP 50mg/5ml, 150mg/15ml, 450mg/45ml, 600mg/60ml Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Carboplatin Dosage & Rx Info | Carboplatin Uses, Side Effects Carboplatin: Indications, Side Effects, Warnings, Carboplatin -Drug Information –Taj Pharma, Carboplatin dose Taj pharmaceuticals Carboplatin interactions, Taj Pharmaceutical Carboplatin contraindications, Carboplatin price, Carboplatin Taj Pharma Carboplatin SmPC-Taj Pharma Stay connected to all updated on Carboplatin Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
Rabeprazole 20mg gastro resistant tablets smpc- taj pharmaceuticalsTaj Pharma
Rabeprazole Taj Pharma : Uses, Side Effects, Interactions, Pictures, Warnings, Rabeprazole Dosage & Rx Info | Rabeprazole Uses, Side Effects -: Indications, Side Effects, Warnings, Rabeprazole - Drug Information - Taj Pharma, Rabeprazole dose Taj pharmaceuticals Rabeprazole interactions, Taj Pharmaceutical Rabeprazole contraindications, Rabeprazole price, Rabeprazole Taj Pharma Rabeprazole 20mg Gastro-resistant Tablets SMPC- Taj Pharma . Stay connected to all updated on Rabeprazole Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Captopril Tablets SmPC Taj PharmaceuticalsTajPharmaQC
Captopril Tablets USP 25mg, 50mg, 100mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Captopril Dosage & Rx Info | Captopril Uses, Side Effects Captopril: Indications, Side Effects, Warnings, Captopril -Drug Information –Taj Pharma, Captopril dose Taj pharmaceuticals Captopril interactions, Taj Pharmaceutical Captopril contraindications, Captopril price, Captopril Taj Pharma Captopril SmPC- Taj Pharma Stay connected to all updated on Captopril Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
Chlorambucil Tablets 2mg USP Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Chlorambucil Dosage & Rx Info | Chlorambucil Uses, Side Effects Chlorambucil: Indications, Side Effects, Warnings, Chlorambucil -Drug Information –Taj Pharma, Chlorambucil dose Taj pharmaceuticals Chlorambucil interactions, Taj Pharmaceutical Chlorambucil contraindications, Chlorambucil price, Chlorambucil Taj Pharma Chlorambucil SmPC-Taj Pharma Stay connected to all updated on Chlorambucil Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
Cefpodoxime 100mg film coated tablets smpc- taj pharmaceuticalsTaj Pharma
Cefpodoxime Dosage & Rx Info | Cefpodoxime Uses, Side Effects -: Indications, Side Effects, Warnings, Cefpodoxime - Drug Information - Taj Pharma, Cefpodoxime dose Taj pharmaceuticals Cefpodoxime interactions, Taj Pharmaceutical Cefpodoxime contraindications, Cefpodoxime price, Cefpodoxime Taj Pharma Cefpodoxime 100mg Film-Coated Tablets SMPC- Taj Pharma . Stay connected to all updated on Cefpodoxime Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Omeprazole 20mg gastro resistant capsules smpc taj pharmaceuticalsTaj Pharma
Omeprazole - Drug Information - Taj Pharma, Omeprazole dose Taj pharmaceuticals Omeprazole interactions, Taj Pharmaceutical Omeprazole contraindications, Omeprazole price, Omeprazole Taj Pharma Omeprazole 20mg Gastro-resistant Capsules SMPC- Taj Pharma . Stay connected to all updated on Omeprazole Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Cabazitaxel 60 mg concentrate and solvent for solution for infusion smpc taj...Taj Pharma
CABAZITAXEL - Drug Information - Taj Pharma, CABAZITAXEL dose Taj pharmaceuticals CABAZITAXEL interactions, Taj Pharmaceutical CABAZITAXEL contraindications, CABAZITAXEL price, CABAZITAXEL Taj Pharma Cancer, oncologyCABAZITAXEL 60 mg concentrate and solvent for solution for infusion. SMPC- Taj Pharma . Stay connected to all updated on CABAZITAXEL Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Carboplatin Injection BP 50mg/5ml, 150mg/15ml, 450mg/45ml, 600mg/60ml Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Carboplatin Dosage & Rx Info | Carboplatin Uses, Side Effects Carboplatin: Indications, Side Effects, Warnings, Carboplatin -Drug Information –Taj Pharma, Carboplatin dose Taj pharmaceuticals Carboplatin interactions, Taj Pharmaceutical Carboplatin contraindications, Carboplatin price, Carboplatin Taj Pharma Carboplatin SmPC-Taj Pharma Stay connected to all updated on Carboplatin Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
Lapatinib Tablets USP 250mg Taj Pharma SmPCTajPharmaQC
Lapatinib Tablets USP 250mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Lapatinib Dosage & Rx Info | Lapatinib Uses, Side Effects Lapatinib: Indications, Side Effects, Warnings, Lapatinib -Drug Information –Taj Pharma, Lapatinib does Taj pharmaceuticals Lapatinib interactions, Taj Pharmaceutical Lapatinib contraindications, Lapatinib price, Lapatinib Taj Pharma Lapatinib SmPC-Taj Pharma Stay connected to all updated on Lapatinib Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
Everolimus Tablets 5mg, 10mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Everolimus Dosage & Rx Info | Everolimus Uses, Side Effects Everolimus: Indications, Side Effects, Warnings, Everolimus -Drug Information –Taj Pharma, Everolimus dose Taj pharmaceuticals Everolimus interactions, Taj Pharmaceutical Everolimus contraindications, Everolimus price, Everolimus Taj Pharma Everolimus SmPC-Taj Pharma Stay connected to all updated on Everolimus Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
Atorvastatin 40 mg film coated tablets smpc- taj pharmaceuticalsTaj Pharma
Atorvastatin 40mg Tablets Taj Pharma : Uses, Side Effects, Interactions, Pictures, Warnings, Atorvastatin Dosage & Rx Info | Atorvastatin Uses, Side Effects - Atorvastatin : Indications, Side Effects, Warnings, Atorvastatin - Drug Information - Taj Pharma, Atorvastatin dose Taj pharmaceuticals Atorvastatin interactions, Taj Pharmaceutical Atorvastatin contraindications, Atorvastatin price, Atorvastatin Taj Pharma anti-arrhythmics Atorvastatin 40 mg film-coated tablets SMPC- Taj Pharma . Stay connected to all updated on Atorvastatin Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Fludarabine phosphate 25 mgml concentrate for solution for injection or infus...Taj Pharma
FLUDARABINE PHOSPHATE Taj Pharma : Uses, Side Effects, Interactions, Pictures, Warnings, FLUDARABINE PHOSPHATE Dosage & Rx Info | FLUDARABINE PHOSPHATE Uses, Side Effects -: Indications, Side Effects, Warnings, FLUDARABINE PHOSPHATE - Drug Information - Taj Pharma, FLUDARABINE PHOSPHATE dose Taj pharmaceuticals FLUDARABINE PHOSPHATE interactions, Taj Pharmaceutical FLUDARABINE PHOSPHATE contraindications, FLUDARABINE PHOSPHATE price, FLUDARABINE PHOSPHATE Taj Pharma Cancer, oncologyFludarabine phosphate 25 mg/ml Concentrate for Solution for Injection or Infusion. SMPC- Taj Pharma
Metoclopramide Injection USP Taj Pharma SmPCTajPharmaQC
Metoclopramide Injection USP 10mg/2ml Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Metoclopramide Dosage & Rx Info | Metoclopramide Uses, Side Effects Metoclopramide: Indications, Side Effects, Warnings, Metoclopramide -Drug Information –Taj Pharma, Metoclopramide dose Taj pharmaceuticals Metoclopramide interactions, Taj Pharmaceutical Metoclopramide contraindications, Metoclopramide price, Metoclopramide Taj Pharma Metoclopramide SmPC-Taj Pharma Stay connected to all updated on Metoclopramide Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Aripiperazole Tablets SmPC Taj PharmaceuticalsTajPharmaQC
Aripiprazole Tablets 10mg, 15mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Aripiprazole Dosage & Rx Info | Aripiprazole Uses, Side Effects Aripiprazole: Indications, Side Effects, Warnings, Aripiprazole -Drug Information –Taj Pharma, Aripiprazole dose Taj pharmaceuticals Aripiprazole interactions, Taj Pharmaceutical Aripiprazole contraindications, Aripiprazole price, Aripiprazole Taj Pharma Aripiprazole SmPC- Taj Pharma Stay connected to all updated on Aripiprazole Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
Paracetamol and ibuprofen 500 mg and 150 mg film coated tablets smpc taj pha...Taj Pharma
Paracetamol and Ibuprofen - Drug Information - Taj Pharma, Paracetamol and Ibuprofen dose Taj pharmaceuticals Paracetamol and Ibuprofen interactions, Taj Pharmaceutical Paracetamol and Ibuprofen contraindications, Paracetamol and Ibuprofen price, Paracetamol and Ibuprofen Taj Pharma Paracetamol and Ibuprofen 500 mg/150 mg film coated tablets SMPC- Taj Pharma . Stay connected to all updated on Paracetamol and Ibuprofen Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Lisinopril Tablets USP 2.5mg, 5mg, 10mg, 20mg, 30mg, 40mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Lisinopril Dosage & Rx Info | Lisinopril Uses, Side Effects Lisinopril: Indications, Side Effects, Warnings, Lisinopril-Drug Information –Taj Pharma, Lisinopril dose Taj pharmaceuticals Lisinopril interactions, Taj Pharmaceutical Lisinopril contraindications, Lisinopril price, Lisinopril Taj Pharma Lisinopril SmPC- Taj Pharma Stay connected to all updated on Lisinopril Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
Carboplatin 10 mgml intravenous infusion smpc taj pharmaceuticalsTaj Pharma
CARBOPLATIN - Drug Information - Taj Pharma, CARBOPLATIN dose Taj pharmaceuticals CARBOPLATINinteractions, Taj Pharmaceutical CARBOPLATIN contraindications, CARBOPLATIN price, CARBOPLATIN Taj Pharma Cancer, oncologyCarboplatin 10 mg/ml Intravenous Infusion SMPC- Taj Pharma . Stay connected to all updated on CARBOPLATIN Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Lisinopril 10mg tablets smpc taj pharmaceuticalsTaj Pharma
Lisinopril 10mg Tablets Taj Pharma : Uses, Side Effects, Interactions, Pictures, Warnings, Lisinopril Dosage & Rx Info | Lisinopril Uses, Side Effects - Lisinopril: Indications, Side Effects, Warnings, Lisinopril - Drug Information - Taj Pharma, Lisinopril dose Taj pharmaceuticals Lisinopril interactions, Taj Pharmaceutical Lisinopril contraindications, Lisinopril price, Lisinopril Taj Pharma Lisinopril 10mg Tablets SMPC- Taj Pharma . Stay connected to all updated on Lisinopril Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Clozapine Tablets USP 25mg, 50mg and 100mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Clozapine Dosage & Rx Info | Clozapine Uses, Side Effects Clozapine: Indications, Side Effects, Warnings, Clozapine -Drug Information –Taj Pharma, Clozapine dose Taj pharmaceuticals Clozapine interactions, Taj Pharmaceutical Clozapine contraindications, Clozapine price, Clozapine Taj Pharma Clozapine SmPC-Taj Pharma Stay connected to all updated on Clozapine Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Ciplar (Generic Propranolol Hydrochloride Tablets) is a nonselective beta-adrenergic receptor blocking agent used in the treatment of Hypertension, Angina Pectoris Due to Coronary Atherosclerosis, Atrial Fibrillation, Myocardial Infarction, Migraine, Essential Tremor, Hypertrophic Subaortic Stenosis and Pheochromocytoma.
Pantoprazole Sodium for Injection Taj Pharma SmPCTajPharmaQC
Pantoprazole Sodium for Injection 40mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Pantoprazole Sodium Dosage & Rx Info | Pantoprazole Sodium Uses, Side Effects Vecuronium bromide: Indications, Side Effects, Warnings, Pantoprazole Sodium-Drug Information –Taj Pharma, Pantoprazole Sodium dose Taj pharmaceuticals Pantoprazole Sodium interactions, Taj Pharmaceutical Pantoprazole Sodium contraindications, Pantoprazole Sodium price, Pantoprazole Sodium Taj Pharma Pantoprazole Sodium SmPC-Taj Pharma Stay connected to all updated on Pantoprazole Sodium Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Lapatinib Tablets USP 250mg Taj Pharma SmPCTajPharmaQC
Lapatinib Tablets USP 250mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Lapatinib Dosage & Rx Info | Lapatinib Uses, Side Effects Lapatinib: Indications, Side Effects, Warnings, Lapatinib -Drug Information –Taj Pharma, Lapatinib does Taj pharmaceuticals Lapatinib interactions, Taj Pharmaceutical Lapatinib contraindications, Lapatinib price, Lapatinib Taj Pharma Lapatinib SmPC-Taj Pharma Stay connected to all updated on Lapatinib Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
Everolimus Tablets 5mg, 10mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Everolimus Dosage & Rx Info | Everolimus Uses, Side Effects Everolimus: Indications, Side Effects, Warnings, Everolimus -Drug Information –Taj Pharma, Everolimus dose Taj pharmaceuticals Everolimus interactions, Taj Pharmaceutical Everolimus contraindications, Everolimus price, Everolimus Taj Pharma Everolimus SmPC-Taj Pharma Stay connected to all updated on Everolimus Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
Atorvastatin 40 mg film coated tablets smpc- taj pharmaceuticalsTaj Pharma
Atorvastatin 40mg Tablets Taj Pharma : Uses, Side Effects, Interactions, Pictures, Warnings, Atorvastatin Dosage & Rx Info | Atorvastatin Uses, Side Effects - Atorvastatin : Indications, Side Effects, Warnings, Atorvastatin - Drug Information - Taj Pharma, Atorvastatin dose Taj pharmaceuticals Atorvastatin interactions, Taj Pharmaceutical Atorvastatin contraindications, Atorvastatin price, Atorvastatin Taj Pharma anti-arrhythmics Atorvastatin 40 mg film-coated tablets SMPC- Taj Pharma . Stay connected to all updated on Atorvastatin Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Fludarabine phosphate 25 mgml concentrate for solution for injection or infus...Taj Pharma
FLUDARABINE PHOSPHATE Taj Pharma : Uses, Side Effects, Interactions, Pictures, Warnings, FLUDARABINE PHOSPHATE Dosage & Rx Info | FLUDARABINE PHOSPHATE Uses, Side Effects -: Indications, Side Effects, Warnings, FLUDARABINE PHOSPHATE - Drug Information - Taj Pharma, FLUDARABINE PHOSPHATE dose Taj pharmaceuticals FLUDARABINE PHOSPHATE interactions, Taj Pharmaceutical FLUDARABINE PHOSPHATE contraindications, FLUDARABINE PHOSPHATE price, FLUDARABINE PHOSPHATE Taj Pharma Cancer, oncologyFludarabine phosphate 25 mg/ml Concentrate for Solution for Injection or Infusion. SMPC- Taj Pharma
Metoclopramide Injection USP Taj Pharma SmPCTajPharmaQC
Metoclopramide Injection USP 10mg/2ml Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Metoclopramide Dosage & Rx Info | Metoclopramide Uses, Side Effects Metoclopramide: Indications, Side Effects, Warnings, Metoclopramide -Drug Information –Taj Pharma, Metoclopramide dose Taj pharmaceuticals Metoclopramide interactions, Taj Pharmaceutical Metoclopramide contraindications, Metoclopramide price, Metoclopramide Taj Pharma Metoclopramide SmPC-Taj Pharma Stay connected to all updated on Metoclopramide Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Aripiperazole Tablets SmPC Taj PharmaceuticalsTajPharmaQC
Aripiprazole Tablets 10mg, 15mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Aripiprazole Dosage & Rx Info | Aripiprazole Uses, Side Effects Aripiprazole: Indications, Side Effects, Warnings, Aripiprazole -Drug Information –Taj Pharma, Aripiprazole dose Taj pharmaceuticals Aripiprazole interactions, Taj Pharmaceutical Aripiprazole contraindications, Aripiprazole price, Aripiprazole Taj Pharma Aripiprazole SmPC- Taj Pharma Stay connected to all updated on Aripiprazole Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
Paracetamol and ibuprofen 500 mg and 150 mg film coated tablets smpc taj pha...Taj Pharma
Paracetamol and Ibuprofen - Drug Information - Taj Pharma, Paracetamol and Ibuprofen dose Taj pharmaceuticals Paracetamol and Ibuprofen interactions, Taj Pharmaceutical Paracetamol and Ibuprofen contraindications, Paracetamol and Ibuprofen price, Paracetamol and Ibuprofen Taj Pharma Paracetamol and Ibuprofen 500 mg/150 mg film coated tablets SMPC- Taj Pharma . Stay connected to all updated on Paracetamol and Ibuprofen Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Lisinopril Tablets USP 2.5mg, 5mg, 10mg, 20mg, 30mg, 40mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Lisinopril Dosage & Rx Info | Lisinopril Uses, Side Effects Lisinopril: Indications, Side Effects, Warnings, Lisinopril-Drug Information –Taj Pharma, Lisinopril dose Taj pharmaceuticals Lisinopril interactions, Taj Pharmaceutical Lisinopril contraindications, Lisinopril price, Lisinopril Taj Pharma Lisinopril SmPC- Taj Pharma Stay connected to all updated on Lisinopril Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
Carboplatin 10 mgml intravenous infusion smpc taj pharmaceuticalsTaj Pharma
CARBOPLATIN - Drug Information - Taj Pharma, CARBOPLATIN dose Taj pharmaceuticals CARBOPLATINinteractions, Taj Pharmaceutical CARBOPLATIN contraindications, CARBOPLATIN price, CARBOPLATIN Taj Pharma Cancer, oncologyCarboplatin 10 mg/ml Intravenous Infusion SMPC- Taj Pharma . Stay connected to all updated on CARBOPLATIN Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Lisinopril 10mg tablets smpc taj pharmaceuticalsTaj Pharma
Lisinopril 10mg Tablets Taj Pharma : Uses, Side Effects, Interactions, Pictures, Warnings, Lisinopril Dosage & Rx Info | Lisinopril Uses, Side Effects - Lisinopril: Indications, Side Effects, Warnings, Lisinopril - Drug Information - Taj Pharma, Lisinopril dose Taj pharmaceuticals Lisinopril interactions, Taj Pharmaceutical Lisinopril contraindications, Lisinopril price, Lisinopril Taj Pharma Lisinopril 10mg Tablets SMPC- Taj Pharma . Stay connected to all updated on Lisinopril Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Clozapine Tablets USP 25mg, 50mg and 100mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Clozapine Dosage & Rx Info | Clozapine Uses, Side Effects Clozapine: Indications, Side Effects, Warnings, Clozapine -Drug Information –Taj Pharma, Clozapine dose Taj pharmaceuticals Clozapine interactions, Taj Pharmaceutical Clozapine contraindications, Clozapine price, Clozapine Taj Pharma Clozapine SmPC-Taj Pharma Stay connected to all updated on Clozapine Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Ciplar (Generic Propranolol Hydrochloride Tablets) is a nonselective beta-adrenergic receptor blocking agent used in the treatment of Hypertension, Angina Pectoris Due to Coronary Atherosclerosis, Atrial Fibrillation, Myocardial Infarction, Migraine, Essential Tremor, Hypertrophic Subaortic Stenosis and Pheochromocytoma.
Pantoprazole Sodium for Injection Taj Pharma SmPCTajPharmaQC
Pantoprazole Sodium for Injection 40mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Pantoprazole Sodium Dosage & Rx Info | Pantoprazole Sodium Uses, Side Effects Vecuronium bromide: Indications, Side Effects, Warnings, Pantoprazole Sodium-Drug Information –Taj Pharma, Pantoprazole Sodium dose Taj pharmaceuticals Pantoprazole Sodium interactions, Taj Pharmaceutical Pantoprazole Sodium contraindications, Pantoprazole Sodium price, Pantoprazole Sodium Taj Pharma Pantoprazole Sodium SmPC-Taj Pharma Stay connected to all updated on Pantoprazole Sodium Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Rabeprazole for Injection Taj Pharma SmPCTajPharmaQC
Rabeprazole for Injection 20mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Rabeprazole Dosage & Rx Info | Rabeprazole Uses, Side Effects Rabeprazole: Indications, Side Effects, Warnings, Rabeprazole -Drug Information –Taj Pharma, Rabeprazole dose Taj pharmaceuticals Rabeprazole interactions, Taj Pharmaceutical Rabeprazole contraindications, Rabeprazole price, Rabeprazole Taj Pharma Rabeprazole SmPC-Taj Pharma Stay connected to all updated on Rabeprazole Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Direct oral anticoagulants (DOACs) have quickly become attractive alternatives to the long‐standing standard of care in anticoagulation, vitamin K antagonist. DOACs are indicated for prevention and treatment of several cardiovascular conditions. Since the first approval in 2010, DOACs have emerged as leading therapeutic alternatives that provide both clinicians and patients with more effective, safe, and convenient treatment options in thromboembolic settings. With the expanding role of DOACs, clinicians are faced with increasingly complex decisions relating to appropriate agent, duration of treatment, and use in special populations. This review will provide an overview of DOACs and act as a practical reference for clinicians to optimize DOAC use among common challenging scenarios. Topics addressed include (1) appropriate indications; (2) use in patients with specific comorbidities; (3) monitoring parameters; (4) transitioning between anticoagulant regimens; (5) major drug interactions; and (6) cost considerations.
Direct oral anticoagulants (DOACs)—dabigatran (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), edoxaban (Savaysa), and betrixaban (Bevyxxa) are anticoagulation pharmacotherapy used for the prevention of thrombosis in several cardiovascular contexts.1 DOACs are categorized into 2 main classes: oral direct factor Xa inhibitors (ie, rivaroxaban, apixaban, edoxaban, and betrixaban) and direct thrombin inhibitors (ie, dabigatran). In 2010, the US Food and Drug Administration (FDA) approved its first DOAC, dabigatran, followed by rivaroxaban, apixaban, edoxaban, and betrixaban in the following years. DOACs are relatively new agents demonstrating superiority or noninferiority to prior standards of care, anticoagulation with vitamin K antagonists (VKA; ie, warfarin), or low‐molecular‐weight heparins (LMWHs), in reducing risk of thromboembolic complications with similar or reduced bleeding risk.2, 3, 4, 5 Advantages of DOACs compared with VKAs include fewer monitoring requirements, less frequent follow‐up, more immediate drug onset and offset effects (important for periprocedural and acute bleeding management), and fewer drug and food interactions.6 As a result, DOAC prescriptions exceeded those for warfarin by 2013, with apixaban being the most frequently prescribed DOAC for patients with nonvalvular atrial fibrillation (NVAF).7
Over the past decade, DOACs have been the subject of extensive investigation in many clinical scenarios. Though guidelines and review articles have provided detailed and in‐depth analyses of the immense literature base, these can be too cumbersome and challenging to integrate into everyday clinical use
In general, FDA‐approved indications for each of the DOACs are comparable (see Table 1). Dabigatran, rivaroxaban, apixaban, and edoxaban are approved for the lowering the risk of stroke and embolism in NVAF as well as deep vein thrombosis and pulmonary embolism treatment/prophylaxis.8, 9, 10, 11 Unique indications
Rabicip (Generic Rabeprazole Sodium Tablets) is used to treat Gastroesophageal Reflux Disease (GERD), treat heartburn, treat or prevent GI (gastrointestinal) ulcers caused by infection, treat or prevent ulcers of the swallowing tube (esophagus)and treat syndromes caused by lots of stomach acid including Zollinger-Ellison syndrome in adults and treatment of symptomatic GERD in adolescent patients 12 years of age and older.
Piroxicam 20mg capsules smpc taj pharmaceuticalsTaj Pharma
Piroxicam Taj Pharma : Uses, Side Effects, Interactions, Pictures, Warnings, Piroxicam Dosage & Rx Info | Piroxicam Uses, Side Effects -: Indications, Side Effects, Warnings, Piroxicam - Drug Information - Taj Pharma, Piroxicam dose Taj pharmaceuticals Piroxicam interactions, Taj Pharmaceutical Piroxicam contraindications, Piroxicam price, Piroxicam Taj Pharma Piroxicam 20mg Capsules SMPC- Taj Pharma . Stay connected to all updated on Piroxicam Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Telbivudine Tablet 600mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Telbivudine Dosage & Rx Info | Telbivudine Uses, Side Effects Telbivudine: Indications, Side Effects, Warnings, Telbivudine -Drug Information –Taj Pharma, Telbivudine dose Taj pharmaceuticals Telbivudine interactions, Taj Pharmaceutical Telbivudine contraindications, Telbivudine price, Telbivudine Taj Pharma Telbivudine SmPC-Taj Pharma Stay connected to all updated on Telbivudine Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Raltegravir Tablets USP Taj Pharma SmPCTajPharmaQC
Raltegravir Tablet USP 25mg/100mg/400mg/600mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Raltegravir Dosage & Rx Info | Raltegravir Uses, Side Effects Raltegravir: Indications, Side Effects, Warnings, Raltegravir -Drug Information –Taj Pharma, Raltegravir dose Taj pharmaceuticals Raltegravir interactions, Taj Pharmaceutical Raltegravir contraindications, Raltegravir price, Raltegravir Taj Pharma Raltegravir SmPC-Taj Pharma Stay connected to all updated on Raltegravir Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Linezolid Tablets USP 600mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Linezolid Dosage & Rx Info | Linezolid Uses, Side Effects Linezolid: Indications, Side Effects, Warnings, Linezolid -Drug Information –Taj Pharma, Linezolid dose Taj pharmaceuticals Linezolid interactions, Taj Pharmaceutical Linezolid contraindications, Linezolid price, Linezolid Taj Pharma Linezolid SmPC-Taj Pharma Stay connected to all updated on Linezolid Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Lacosamide Tablets 50mg/100mg/150mg/200mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Lacosamide Dosage & Rx Info | Lacosamide Uses, Side Effects Lacosamide : Indications, Side Effects, Warnings, Lacosamide-Drug Information –Taj Pharma, Lacosamide dose Taj pharmaceuticals Lacosamide interactions, Taj Pharmaceutical Lacosamide contraindications, Lacosamide price, Lacosamide Taj Pharma Lacosamide SmPC-Taj Pharma Stay connected to all updated on Lacosamide Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Digoxin Tablets USP 62.5mcg/125mcg/250mcg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Digoxin Dosage & Rx Info | Digoxin Uses, Side Effects Digoxin : Indications, Side Effects, Warnings, Digoxin -Drug Information –Taj Pharma, Digoxin dose Taj pharmaceuticals Digoxin interactions, Taj Pharmaceutical Digoxin contraindications, Digoxin price, Digoxin Taj Pharma Digoxin SmPC-Taj Pharma Stay connected to all updated on Digoxin Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Digoxin Tablets USP 62.5mcg/125mcg/250mcg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Digoxin Dosage & Rx Info | Digoxin Uses, Side Effects Digoxin : Indications, Side Effects, Warnings, Digoxin -Drug Information –Taj Pharma, Digoxin dose Taj pharmaceuticals Digoxin interactions, Taj Pharmaceutical Digoxin contraindications, Digoxin price, Digoxin Taj Pharma Digoxin SmPC-Taj Pharma Stay connected to all updated on Digoxin Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Ciprofloxacin Tablets USP 250mg/500mg/750mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Ciprofloxacin Dosage & Rx Info | Ciprofloxacin Uses, Side Effects Ciprofloxacin : Indications, Side Effects, Warnings, Ciprofloxacin -Drug Information –Taj Pharma, Ciprofloxacin dose Taj pharmaceuticals Ciprofloxacin interactions, Taj Pharmaceutical Ciprofloxacin contraindications, Ciprofloxacin price, Ciprofloxacin Taj Pharma Ciprofloxacin SmPC-Taj Pharma Stay connected to all updated on Ciprofloxacin Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Azithromycin Tablets USP 250mg/500mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Azithromycin Dosage & Rx Info | Azithromycin Uses, Side Effects Azithromycin: Indications, Side Effects, Warnings, Azithromycin -Drug Information –Taj Pharma, Azithromycin dose Taj pharmaceuticals Azithromycin interactions, Taj Pharmaceutical Azithromycin contraindications, Azithromycin price, Azithromycin Taj Pharma Azithromycin SmPC-Taj Pharma Stay connected to all updated on Azithromycin Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Atomoxetine Capsules USP Taj Pharma SmPCTajPharmaQC
Atomoxetine Capsules USP 10mg/18mg/25mg/40mg/60mg/80mg/100mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Atomoxetine Dosage & Rx Info | Atomoxetine Uses, Side Effects Atomoxetine: Indications, Side Effects, Warnings, Atomoxetine -Drug Information –Taj Pharma, Atomoxetine dose Taj pharmaceuticals Atomoxetine interactions, Taj Pharmaceutical Atomoxetine contraindications, Atomoxetine price, Atomoxetine Taj Pharma Atomoxetine SmPC-Taj Pharma Stay connected to all updated on Atomoxetine Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Vildagliptin Tablets 50mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Vildagliptin Dosage & Rx Info | Vildagliptin Uses, Side Effects Vildagliptin: Indications, Side Effects, Warnings, Vildagliptin -Drug Information –Taj Pharma, Vildagliptin dose Taj pharmaceuticals Vildagliptin interactions, Taj Pharmaceutical Vildagliptin contraindications, Vildagliptin price, Vildagliptin Taj Pharma Vildagliptin SmPC-Taj Pharma Stay connected to all updated on Vildagliptin Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Theophylline Extended-Release Tablets 100mg, 200mg, 300mg, 400mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Theophylline Dosage & Rx Info | Theophylline Uses, Side Effects Theophylline: Indications, Side Effects, Warnings, Theophylline -Drug Information –Taj Pharma, Theophylline dose Taj pharmaceuticals Theophylline interactions, Taj Pharmaceutical Theophylline contraindications, Theophylline price, Theophylline Taj Pharma Theophylline SmPC-Taj Pharma Stay connected to all updated on Theophylline Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Sofosbuvir/Velpatasvir Tablets Taj Pharma SmPCTajPharmaQC
Sofosbuvir/Velpatasvir Tablets 400mg/100mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Sofosbuvir/Velpatasvir Dosage & Rx Info | Sofosbuvir/Velpatasvir Uses, Side Effects Sofosbuvir/Velpatasvir: Indications, Side Effects, Warnings, Sofosbuvir/Velpatasvir -Drug Information –Taj Pharma, Sofosbuvir/Velpatasvir dose Taj pharmaceuticals Sofosbuvir/Velpatasvir interactions, Taj Pharmaceutical Sofosbuvir/Velpatasvir contraindications, Sofosbuvir/Velpatasvir price, Sofosbuvir/Velpatasvir Taj Pharma Sofosbuvir/Velpatasvir SmPC-Taj Pharma Stay connected to all updated on Sofosbuvir/Velpatasvir Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Sofosbuvir Tablets 400mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Sofosbuvir Dosage & Rx Info | Sofosbuvir Uses, Side Effects Sofosbuvir: Indications, Side Effects, Warnings, Sofosbuvir -Drug Information –Taj Pharma, Sofosbuvir dose Taj pharmaceuticals Sofosbuvir interactions, Taj Pharmaceutical Sofosbuvir contraindications, Sofosbuvir price, Sofosbuvir Taj Pharma Sofosbuvir SmPC-Taj Pharma Stay connected to all updated on Sofosbuvir Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
Nicorandil Tablets BP 10mg, 20mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Nicorandil Dosage & Rx Info | Nicorandil Uses, Side Effects Nicorandil: Indications, Side Effects, Warnings, Nicorandil -Drug Information –Taj Pharma, Nicorandil dose Taj pharmaceuticals Nicorandil interactions, Taj Pharmaceutical Nicorandil contraindications, Nicorandil price, Nicorandil Taj Pharma Nicorandil SmPC-Taj Pharma Stay connected to all updated on Nicorandil Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SmPC.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Rabeprazole Sodium 10mg/20mg/40mg Tablets Taj Pharma SmPC
1. Rabeprazole Sodium Gastro-
Resistant Tablets IP
10mg/20mg/40mg (RABTAJ)
Taj Pharma
1. Name of the medicinal
product
Rabeprazole Sodium Gastro-Resistant
Tablets IP 10mg (RABTAJ) Taj Pharma
Rabeprazole Sodium Gastro-Resistant
Tablets IP 20mg (RABTAJ) Taj Pharma
Rabeprazole Sodium Gastro-Resistant
Tablets IP 40mg (RABTAJ) Taj Pharma
2. Qualitative and quantitative
composition
a) Each gastro-resistant tablet contains:
Rabeprazole sodium, equivalent to
Rabeprazole IP……………………………10mg
b) Each gastro-resistant tablet contains:
Rabeprazole sodium, equivalent to
Rabeprazole IP……………………………20mg
c) Each gastro-resistant tablet contains:
Rabeprazole sodium, equivalent to
Rabeprazole IP……………………………40mg
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Gastro-resistant tablet
4. Clinical particulars
4.1 Therapeutic indications
Rabeprazole tablets are indicated for the
treatment of:
• Active duodenal ulcer
• Active benign gastric ulcer
• Symptomatic erosive or ulcerative gastro-
oesophageal reflux disease (GORD).
• Gastro-Oesophageal Reflux Disease Long-term
Management (GORD Maintenance)
• Symptomatic treatment of moderate to very
severe gastro-oesophageal reflux disease
(symptomatic GORD)
• Zollinger-Ellison Syndrome
4.2 Posology and method of administration
Adults/elderly:
Active Duodenal Ulcer and Active Benign
Gastric Ulcer: The recommended oral dose for
both active duodenal ulcer and active benign
gastric ulcer is 20mg to be taken once daily in
the morning.
Most patients with active duodenal ulcer heal
within four weeks. However a few patients may
require an additional four weeks of therapy to
achieve healing. Most patients with active
benign gastric ulcer heal within six weeks.
However again a few patients may require an
additional six weeks of therapy to achieve
healing.
Erosive or Ulcerative Gastro-Oesophageal
Reflux Disease (GORD): The recommended oral
dose for this condition is 20mg to be taken once
daily for four to eight weeks.
Gastro-Oesophageal Reflux Disease Long-term
Management (GORD Maintenance): For long-
term management, a maintenance dose of
Rabeprazole Sodium20mg or 10mg once daily
can be used depending upon patient response.
Symptomatic treatment of moderate to very
severe gastro-oesophageal reflux disease
(symptomatic GORD): 10mg once daily in
patients without oesophagitis. If symptom
control has not been achieved during four
weeks, the patient should be further investigated.
Once symptoms have resolved, subsequent
symptom control can be achieved using an on-
demand regimen taking 10mg once daily when
needed.
Zollinger-Ellison Syndrome: The recommended
adult starting dose is 60 mg once a day. The
dose may be titrated upwards to 120mg/day
based on individual patient needs. Single daily
2. doses up to 100mg/day may be given. 120mg
dose may require divided doses, 60mg twice
daily. Treatment should continue for as long as
clinically indicated.
For indications requiring once daily treatment
Rabeprazole Sodium tablets should be taken in
the morning, before eating; and although neither
the time of day nor food intake was shown to
have any effect on rabeprazole sodium activity,
this regimen will facilitate treatment
compliance.
Patients should be cautioned that the
Rabeprazole Sodium tablets should not be
chewed or crushed, but should be swallowed
whole.
Renal and hepatic impairment: No dosage
adjustment is necessary for patients with renal or
hepatic impairment.
See section 4.4 Special Warnings and
Precautions for Use of Rabeprazole Sodium in
the treatment of patients with severe hepatic
impairment.
Children:
Rabeprazole Sodium is not recommended for
use in children, as there is no experience of its
use in this group.
4.3 Contraindications
Rabeprazole Sodium is contra-indicated in
patients with known hypersensitivity to
rabeprazole sodium, substituted benzimidazoles
or to any excipient used in the formulation listed
in section 6.1.
Rabeprazole Sodium is contra-indicated in
pregnancy and during breast feeding.
4.4 Special warnings and precautions for use
Symptomatic response to therapy with
rabeprazole sodium does not preclude the
presence of gastric or oesophageal malignancy,
therefore the possibility of malignancy should be
excluded prior to commencing treatment with
Rabeprazole Sodium.
Patients on long-term treatment (particularly
those treated for more than a year) should be
kept under regular surveillance.
A risk of cross-hypersensitivity reactions with
other proton pump inhibitor or substituted
benzimidazoles cannot be excluded.
Patients should be cautioned that Rabeprazole
Sodium tablets should not be chewed or crushed,
but should be swallowed whole.
Rabeprazole Sodium is not recommended for
use in children, as there is no experience of its
use in this group.
There have been post marketing reports of blood
dyscrasias (thrombocytopenia and neutropenia).
In the majority of cases where an alternative
aetiology cannot be identified, the events were
uncomplicated and resolved on discontinuation
of rabeprazole.
Hepatic enzyme abnormalities have been seen in
clinical trials and have also been reported since
market authorisation. In the majority of cases
where an alternative aetiology cannot be
identified, the events were uncomplicated and
resolved on discontinuation of rabeprazole.
No evidence of significant drug related safety
problems was seen in a study of patients with
mild to moderate hepatic impairment versus
normal age and sex matched controls. However
because there are no clinical data on the use of
rabeprazole in the treatment of patients with
severe hepatic dysfunction the prescriber is
advised to exercise caution when treatment with
Rabeprazole Sodium is first initiated in such
patients.
Co-administration of atazanavir with
rabeprazole is not recommended (see section
4.5).
Treatment with proton pump inhibitors,
including Rabeprazole Sodium, may possibly
increase the risk of gastrointestinal infections
such
as Salmonella, Campylobacter and Clostridium
difficile (see section 5.1).
3. Proton pump inhibitors, especially if used in
high doses and over long durations (>1 year),
may modestly increase the risk of hip, wrist and
spine fracture, predominantly in the elderly or in
presence of other recognised risk factors.
Observational studies suggest that proton pump
inhibitors may increase the overall risk of
fracture by 10–40%. Some of this increase may
be due to other risk factors. Patients at risk of
osteoporosis should receive care according to
current clinical guidelines and they should have
an adequate intake of vitamin D and calcium.
Hypomagnesaemia
Severe hypomagnesaemia has been reported in
patients treated with PPIs like rabeprazole for at
least three months, and in most cases for a year.
Serious manifestations of hypomagnesaemia
such as fatigue, tetany, delirium, convulsions,
dizziness and ventricular arrhythmia can occur
but they may begin insidiously and be
overlooked. In most affected patients,
hypomagnesaemia improved after magnesium
replacement and discontinuation of the PPI.
For patients expected to be on prolonged
treatment or who take PPIs with digoxin or
drugs that may cause hypomagnesaemia (e.g.,
diuretics), health care professionals should
consider measuring magnesium levels before
starting PPI treatment and periodically during
treatment.
Concomitant use of Rabeprazole with
Methotrexate
Literature suggests that concomitant use of PPIs
with methotrexate (primarily at high dose; see
methotrexate prescribing information) may
elevate and prolong serum levels of
methotrexate and/or its metabolite, possibly
leading to methotrexate toxicities. In highdose
methotrexate administration, a temporary
withdrawal of the PPI may be considered in
some patients.
Influence on vitamin B12 absorption
Rabeprazole sodium, as all acidblocking
medicines, may reduce the absorption of vitamin
B12 (cyanocobalamin) due to hypo- or a-
chlorhydria.This should be considered in
patients with reduced body stores or risk factors
for reduced vitamin B12 absorption on longterm
therapy or if respective clinical symptoms are
observed.
Subacute cutaneous lupus erythematosus
(SCLE)
Proton pump inhibitors are associated with very
infrequent cases of SCLE. If lesions occur,
especially in sun-exposed areas of the skin, and
if accompanied by arthralgia, the patient should
seek medical help promptly and the health care
professional should consider stopping
Rabeprazole Sodium. SCLE after previous
treatment with a proton pump inhibitor may
increase the risk of SCLE with other proton
pump inhibitors.
Interference with laboratory tests
Increased Chromogranin A (CgA) level may
interfere with investigations for neuroendocrine
tumours. To avoid this interference, rabeprazole
sodium treatment should be stopped for at least
5 days before CgA measurements (see section
5.1). If CgA and gastrin levels have not returned
to reference range after initial measurement,
measurements should be repeated 14 days after
cessation of proton pump inhibitor treatment.
4.5 Interaction with other medicinal products
and other forms of interaction
Rabeprazole sodium produces a profound and
long lasting inhibition of gastric acid secretion.
An interaction with compounds whose
absorption is pH dependent may occur. Co-
administration of rabeprazole sodium with
ketoconazole or itraconazole may result in a
significant decrease in antifungal plasma levels.
Therefore individual patients may need to be
monitored to determine if a dosage adjustment is
necessary when ketoconazole or itraconazole are
taken concomitantly with rabeprazole.
In clinical trials, antacids were used
concomitantly with the administration of
rabeprazole and, in a specific drug-drug
interaction study, no interaction with liquid
antacids was observed.
4. Co-administration of atazanavir 300mg/ritonavir
100mg with omeprazole (40 mg once daily) or
atazanavir 400mg with lansoprazole (60mg once
daily) to healthy volunteers resulted in a
substantial reduction in atazanavir exposure. The
absorption of atazanavir is pH dependent.
Although not studied, similar results are
expected with other proton pump inhibitors.
Therefore PPIs, including rabeprazole, should
not be co-administered with atazanavir (see
Section 4.4).
Methotrexate
Case reports, published population
pharmacokinetic studies, and retrospective
analyses suggest that concomitant administration
of PPIs and methotrexate (primarily at high
dose; see methotrexate prescribing information)
may elevate and prolong serum levels of
methotrexate and/or its metabolite
hydroxymethotrexate. However, no formal drug
interaction studies of methotrexate with PPIs
have been conducted.
4.6 Fertility, pregnancy and lactation
Pregnancy:
There are no data on the safety of rabeprazole in
human pregnancy. Reproduction studies
performed in rats and rabbits have revealed no
evidence of impaired fertility or harm to the
foetus due to rabeprazole sodium, although low
foeto-placental transfer occurs in rats.
Rabeprazole Sodium is contraindicated during
pregnancy.
Lactation:
It is not known whether rabeprazole sodium is
excreted in human breast milk. No studies in
lactating women have been performed.
Rabeprazole sodium is however excreted in rat
mammary secretions. Therefore Rabeprazole
Sodium should not be used during breast
feeding.
4.7 Effects on ability to drive and use
machines
Based on the pharmacodynamic properties and
the adverse events profile, it is unlikely that
Rabeprazole would cause an impairment of
driving performance or compromise the ability
to use machinery. If however, alertness is
impaired due to somnolence, it is recommended
that driving and operating complex machinery
be avoided.
4.8 Undesirable effects
The most commonly reported adverse drug
reactions, during controlled clinical trials with
rabeprazole were headache, diarrhoea,
abdominal pain, asthenia, flatulence, rash and
dry mouth. The majority of adverse events
experienced during clinical studies were mild or
moderate in severity, and transient in nature.
The following adverse events have been
reported from clinical trial and post-marketed
experience.
Frequencies are defined as: common (>1/100 to
<1/10), uncommon (> 1/1,000 to <1/100), rare
(>1/10,000 to <1/1000) and very rare
(<1/10,000), not known (cannot be estimated
from the available data).
1
Includes facial swelling, hypotension and
dyspnoea
2
Erythema, bullous reactions and
hypersensitivity reactions have usually resolved
after discontinuation of therapy.
3
Rare reports of hepatic encephalopathy have
been received in patients with underlying
cirrhosis. In treatment of patients with severe
hepatic dysfunction the prescriber is advised to
exercise caution when treatment with
Rabeprazole is first initiated in such patients (see
section 4.4)
4
See Special warnings and precautions for use
(4.4)
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after
authorisation of the medicinal product is
important. It allows continued monitoring of the
benefit/risk balance of the medicinal product.
4.9 Overdose
Experience to date with deliberate or accidental
overdose is limited. The maximum established
5. exposure has not exceeded 60mg twice daily, or
160mg once daily. Effects are generally
minimal, representative of the known adverse
event profile and reversible without further
medical intervention. No specific antidote is
known. Rabeprazole sodium is extensively
protein bound and is, therefore, not dialysable.
As in any case of overdose, treatment should be
symptomatic and general supportive measures
should be utilised.
5. Pharmacological properties
5.1 Pharmacodynamic properties
Pharmacotherapeutic group: Alimentary tract
and metabolism, Drugs for peptic ulcer and
gastro-oesophageal reflux disease (GORD),
proton pump inhibitors,
Mechanism of Action: Rabeprazole sodium
belongs to the class of anti-secretory
compounds, the substituted benzimidazoles, that
do not exhibit anticholinergic or H2 histamine
antagonist properties, but suppress gastric acid
secretion by the specific inhibition of the H+
/K+
-
ATPase enzyme (the acid or proton pump) The
effect is dose-related and leads to inhibition of
both basal and stimulated acid secretion
irrespective of the stimulus. Animal studies
indicate that after administration, rabeprazole
sodium rapidly disappears from both the plasma
and gastric mucosa. As a weak base, rabeprazole
is rapidly absorbed following all doses and is
concentrated in the acid environment of the
parietal cells. Rabeprazole is converted to the
active sulphenamide form through protonation
and it subsequently reacts with the available
cysteines on the proton pump.
Anti-secretory Activity: After oral administration
of a 20mg dose of rabeprazole sodium the onset
of the anti-secretory effect occurs within one
hour, with the maximum effect occurring within
two to four hours. Inhibition of basal and food
stimulated acid secretion 23 hours after the first
dose of rabeprazole sodium are 69% and 82%
respectively and the duration of inhibition lasts
up to 48 hours. The inhibitory effect of
rabeprazole sodium on acid secretion increases
slightly with repeated once-daily dosing,
achieving steady state inhibition after three days.
When the drug is discontinued, secretory activity
normalises over 2 to 3 days.
Decreased gastric acidity due to any means,
including proton pump inhibitors such as
rabeprazole, increases counts of bacteria
normally present in the gastrointestinal tract.
Treatment with proton pump inhibitors may
possibly increase the risk of gastrointestinal
infections such
as Salmonella, Campylobacter and Clostridium
difficile.
Serum Gastrin Effects: In clinical studies
patients were treated once daily with 10 or 20mg
rabeprazole sodium, for up to 43 months
duration. Serum gastrin levels increased during
the first 2 to 8 weeks reflecting the inhibitory
effects on acid secretion and remained stable
while treatment was continued. Gastrin values
returned to pre-treatment levels, usually within 1
to 2 weeks after discontinuation of therapy.
Human gastric biopsy specimens from the
antrum and the fundus from over 500 patients
receiving rabeprazole or comparator treatment
for up to 8 weeks have not detected changes in
ECL cell histology, degree of gastritis, incidence
of atrophic gastritis, intestinal metaplasia or
distribution of H. pylori infection. In over 250
patients followed for 36 months of continuous
therapy, no significant change in findings
present at baseline was observed.
Other Effects: Systemic effects of rabeprazole
sodium in the CNS, cardiovascular and
respiratory systems have not been found to date.
Rabeprazole sodium, given in oral doses of
20mg for 2 weeks, had no effect on thyroid
function, carbohydrate metabolism, or
circulating levels of parathyroid hormone,
cortisol, oestrogen, testosterone, prolactin,
cholecystokinin, secretin, glucagon, follicle
stimulating hormone (FSH), luteinising hormone
(LH), renin, aldosterone or somatotrophic
hormone.
Studies in healthy subjects have shown that
rabeprazole sodium does not have clinically
significant interactions with amoxicillin.
6. Rabeprazole does not adversely influence
plasma concentrations of amoxicillin or
clarithromycin when co-administered for the
purpose of eradicating upper gastrointestinal H.
pylori infection.
During treatment with antisecretory medicinal
products, serum gastrin increases in response to
the decreased acid secretion. Also CgA increases
due to decreased gastric acidity. The increased
CgA level may interfere with investigations for
neuroendocrine tumours.
Available published evidence suggests that
proton pump inhibitors should be discontinued
between 5 days and 2 weeks prior to CgA
measurements. This is to allow CgA levels that
might be spuriously elevated following PPI
treatment to return to reference range.
5.2 Pharmacokinetic properties
Absorption: Rabeprazole Sodium is an enteric-
coated (gastro-resistant) tablet formulation of
rabeprazole sodium. This presentation is
necessary because rabeprazole is acid-labile.
Absorption of rabeprazole therefore begins only
after the tablet leaves the stomach. Absorption is
rapid, with peak plasma levels of rabeprazole
occurring approximately 3.5 hours after a 20mg
dose. Peak plasma concentrations (Cmax) of
rabeprazole and AUC are linear over the dose
range of 10mg to 40mg. Absolute bioavailability
of an oral 20mg dose (compared to intravenous
administration) is about 52% due in large part to
pre-systemic metabolism. Additionally the
bioavailability does not appear to increase with
repeat administration. In healthy subjects the
plasma half-life is approximately one hour
(range 0.7 to 1.5 hours), and the total body
clearance is estimated to be 283 ± 98 ml/min.
There was no clinically relevant interaction with
food. Neither food nor the time of day of
administration of the treatment affect the
absorption of rabeprazole sodium.
Distribution: Rabeprazole is approximately 97%
bound to human plasma proteins.
Metabolism and excretion: Rabeprazole sodium,
as is the case with other members of the proton
pump inhibitor (PPI) class of compounds, is
metabolised through the cytochrome P450
(CYP450) hepatic drug metabolising system. In
vitro studies with human liver microsomes
indicated that rabeprazole sodium is metabolised
by isoenzymes of CYP450 (CYP2C19 and
CYP3A4). In these studies, at expected human
plasma concentrations rabeprazole neither
induces nor inhibits CYP3A4; and although in
vitro studies may not always be predictive of in
vivo status these findings indicate that no
interaction is expected between rabeprazole and
cyclosporin. In humans the thioether (M1) and
carboxylic acid (M6) are the main plasma
metabolites with the sulphone (M2), desmethyl-
thioether (M4) and mercapturic acid conjugate
(M5) minor metabolites observed at lower
levels. Only the desmethyl metabolite (M3) has
a small amount of anti-secretory activity, but it
is not present in plasma.
Following a single 20mg 14
C labelled oral dose
of rabeprazole sodium, no unchanged drug was
excreted in the urine. Approximately 90% of the
dose was eliminated in urine mainly as the two
metabolites: a mercapturic acid conjugate (M5)
and a carboxylic acid (M6), plus two unknown
metabolites. The remainder of the dose was
recovered in faeces.
Gender: Adjusted for body mass and height,
there are no significant gender differences in
pharmacokinetic parameters following a single
20mg dose of rabeprazole.
Renal dysfunction: In patients with stable, end-
stage, renal failure requiring maintenance
haemodialysis (creatinine clearance ≤
5ml/min/1.73m2
), the disposition of rabeprazole
was very similar to that in healthy volunteers.
The AUC and the Cmax in these patients was
about 35% lower than the corresponding
parameters in healthy volunteers. The mean half-
life of rabeprazole was 0.82 hours in healthy
volunteers, 0.95 hours in patients during
haemodialysis and 3.6 hours post dialysis. The
clearance of the drug in patients with renal
disease requiring maintenance haemodialysis
was approximately twice that in healthy
volunteers.
7. Hepatic dysfunction: Following a single 20mg
dose of rabeprazole to patients with chronic mild
to moderate hepatic impairment the AUC
doubled and there was a 2-3 fold increase in
half-life of rabeprazole compared to the healthy
volunteers. However, following a 20mg dose
daily for 7 days the AUC had increased to only
1.5-fold and the Cmax to only 1.2-fold. The half-
life of rabeprazole in patients with hepatic
impairment was 12.3 hours compared to 2.1
hours in healthy volunteers. The
pharmacodynamic response (gastric pH control)
in the two groups was clinically comparable.
Elderly: Elimination of rabeprazole was
somewhat decreased in the elderly. Following 7
days of daily dosing with 20mg of rabeprazole
sodium, the AUC approximately doubled, the
Cmax increased by 60% and t½ increased by
approximately 30% as compared to young
healthy volunteers. However there was no
evidence of rabeprazole accumulation.
CYP2C19 Polymorphism: Following a 20mg
daily dose of rabeprazole for 7 days, CYP2C19
slow metabolisers, had AUC and t½ which were
approximately 1.9 and 1.6 times the
corresponding parameters in extensive
metabolisers whilst Cmax had increased by only
40%.
5.3 Preclinical safety data
Non-clinical effects were observed only at
exposures sufficiently in excess of the maximum
human exposure that make concerns for human
safety negligible in respect of animal data.
Studies on mutagenicity gave equivocal results.
Tests in mouse lymphoma cell line were
positive, but in vivo micronucleus and in
vivo and in vitro DNA repair tests were negative.
Carcinogenicity studies revealed no special
hazard for humans.
6. Pharmaceutical particulars
6.1 List of excipients
Tablet core:
Mannitol, Magnesium oxide, Hydroxy
propylcellulose, Crospovidone, Low-substituted
hydroxy propyl cellulose, Magnesium stearate
Under coating:
Ethyl cellulose, Magnesium oxide, heavy
Enteric coating:
Hypromellose phthalate, Diacetylated
monoglycerides, Talc, Titanium dioxide, Yellow
iron oxide
6.2 Incompatibilities
Not applicable
6.3 Shelf life
24 months.
In use shelf life for HDPE bottle pack: 3 months
6.4 Special precautions for storage
Store below 25°C.
Store in the original package in order to protect
from moisture.
6.5 Nature and contents of container
Polyamide/Aluminium/PVC/Aluminium foil
blister packs of 7, 10, 14, 20, 28, 30, 50, 56, 60,
98, 100 and 120 gastro-resistant tablets.
HDPE bottle with tamper proof polypropylene
closure containing silica gel dessicant sachet(s):
30 & 90 gastro-resistant tablets.
Not all pack sizes may be marketed.
6.6 Special precautions for disposal and other
handling
Not applicable
7. Manufactured in India By:
TAJ PHARMACEUTICALS LTD.
Plot no. 220, Mahagujarat, Industrial Estate,
Moraiya, Tal. Sanand, Dist. Ahmedabad,
Gujarat.